<img alt="" height="1" width="1" />Public Database Is Urged to Monitor Drug SafetyNew York Times... Zelnorm, a drug for irritable bowel syndrome, withdrawn by Novartis in 2007 after an analysis of safety data found an increased risk of heart problems; ...<nobr>and more »</nobr> |